onr:"swepub:oai:DiVA.org:uu-184479"
Sökning: onr:"swepub:oai:DiVA.org:uu-184479" > Application of a Lo...
- 1 av 1
- Föregående post
- Nästa post
- Till träfflistan
Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients : Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill
-
- Mohamed, Ami Fazlin Syed (författare)
- Uppsala universitet,Institutionen för farmaceutisk biovetenskap,Farmakometri
- Karaiskos, Ilias (författare)
- Plachouras, Diamantis (författare)
- visa fler...
- Pontikis, Konstantinos (författare)
- Jansson, Britt (författare)
- Papadomichelakis, Evangelos (författare)
- Antoniadou, Anastasia (författare)
- Giamarellou, Helen (författare)
- Armaganidis, Apostolos (författare)
- visa färre...
- (creator_code:org_t)
- 2012
- 2012
- Engelska.
- Ingår i: Antimicrobial Agents and Chemotherapy. - 0066-4804 .- 1098-6596. ; 56:8, s. 4241-4249
- Tidskriftsartikel (refereegranskat)
Abstract
Ämnesord
Stäng
- A previous pharmacokinetic study on dosing of colistin methanesulfonate (CMS) at 240 mg (3 million units [MU]) every 8 h indicated that colistin has a long half-life, resulting in insufficient concentrations for the first 12 to 48 h after initiation of treatment. A loading dose would therefore be beneficial. The aim of this study was to evaluate CMS and colistin pharmacokinetics following a 480-mg (6-MU) loading dose in critically ill patients and to explore the bacterial kill following the use of different dosing regimens obtained by predictions from a pharmacokinetic-pharmacodynamic model developed from an in vitro study on Pseudomonas aeruginosa. The unbound fractions of colistin A and colistin B were determined using equilibrium dialysis and considered in the predictions. Ten critically ill patients (6 males; mean age, 54 years; mean creatinine clearance, 82 ml/min) with infections caused by multidrug-resistant Gram-negative bacteria were enrolled in the study. The pharmacokinetic data collected after the first and eighth doses were analyzed simultaneously with the data from the previous study (total, 28 patients) in the NONMEM program. For CMS, a two-compartment model best described the pharmacokinetics, and the half-lives of the two phases were estimated to be 0.026 and 2.2 h, respectively. For colistin, a one-compartment model was sufficient and the estimated half-life was 18.5 h. The unbound fractions of colistin in the patients were 26 to 41% at clinical concentrations. Colistin A, but not colistin B, had a concentration-dependent binding. The predictions suggested that the time to 3-log-unit bacterial kill for a 480-mg loading dose was reduced to half of that for the dose of 240 mg.
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
- Antimicrobial Agents and Chemotherapy (Sök värdpublikationen i LIBRIS)
Till lärosätets databas
- 1 av 1
- Föregående post
- Nästa post
- Till träfflistan
Hitta mer i SwePub
- Av författaren/redakt...
- Mohamed, Ami Faz ...
- Karaiskos, Ilias
- Plachouras, Diam ...
- Karvanen, Matti
- Pontikis, Konsta ...
- Jansson, Britt
- visa fler...
- Papadomichelakis ...
- Antoniadou, Anas ...
- Giamarellou, Hel ...
- Armaganidis, Apo ...
- Cars, Otto
- Friberg, Lena E.
- visa färre...
- Artiklar i publikationen
- Antimicrobial Ag ...
- Av lärosätet
- Uppsala universitet
Sök utanför SwePub
- Sök vidare i:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - Nationella bibliotekssystem
- LIBRIS.kb.se
